BLEXTEN

aralez pharmaceuticals canada inc🇨🇦 Health Canada

Approval Id: a2f6d6974823f05b
Drug Approval Canada Name: BLEXTEN
Product Name: BLEXTEN
Status: Marketed
Status Date: 2022-02-10
Original Market Date: 2022-02-10
Din: 02519011
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 04:08.00
Atc Original: R06AX29 BILASTINE
Atc Name: r 06 ax 29
Aig Number: 0158051002
Company Name: aralez pharmaceuticals canada inc
Company Address: 6733 Mississauga Rd, Suite 800, Mississauga, Ontario, Canada, L5N 6J5

BILASTINE

2.5 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

a2f6d6974823f05b

Type

Standard